Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

Article

Abstract: Background: Direct oral anticoagulants are administered in fixed doses irrespective of body weight,

Palabras claves:

Cardiovascular Risk, DOAC, prevention, rivaroxaban

Autores:

Berkowitz S.D., Bhatt D.L., Dyal L., Eikelboom J.W., Fox K.A.A., Guzik T.J., Muehlhofer E., PATRICIO LOPEZ -JARAMILLO, Pogosova N., Ramasundarahettige C., Yusuf S.

Fuentes:

google

scopus